Chosa Oncology AB (W5L) Stock Price & News

All values in SEK	Jun. 2025	Sep. 2025	Des. 2025	Mrt. 2026
Revenue	3,94 m	-	676,00 k	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2,02 m	2,48 m	4,07 m	1,96 m
Operating expense	1,43 m	2,49 m	5,40 m	1,96 m
Total operating expenses	1,43 m	2,49 m	5,40 m	1,96 m
Operating income	2,51 m	-2,49 m	-4,72 m	-1,96 m
Other non operating income	119,00 k	-52,00 k	-8,75 k	-2,00 k
EBT including unusual items	2,64 m	-2,54 m	-4,92 m	-1,87 m
EBT excluding unusual items	2,64 m	-2,54 m	-4,92 m	-1,87 m
Income tax expense	-	-	-1,01 m	-
Effective tax rate	-	-	20,60%	-
Other operating expenses	-677,00 k	5,00 k	680,00 k	-2,00 k
Net income	2,64 m	-2,54 m	-3,91 m	-1,87 m
Net profit margin	67,22%	-	-578,11%	-
Earnings per share	-	-	-	-
Interest and investment income	18,00 k	-	310,20 k	95,00 k
Interest expense	-	-	-116,05 k	-2,00 k
Net interest expenses	18,00 k	-	194,16 k	93,00 k
Depreciation and amortization charges	-	-	-	-
EBITDA	2,68 m	-2,46 m	-4,08 m	-1,78 m
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance